1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Upper GIT
        1.2.3 Lower GIT
    1.3 Market by Application
        1.3.1 Global Microbiome Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 C. difficile Infection (CDI)
        1.3.3 Inflammatory Bowel Disease (IBD)
        1.3.4 Orphan Drug
        1.3.5 Immuno-oncology
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Microbiome Therapeutics Market Perspective (2017-2028)
    2.2 Microbiome Therapeutics Growth Trends by Region
        2.2.1 Microbiome Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Microbiome Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Microbiome Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Microbiome Therapeutics Market Dynamics
        2.3.1 Microbiome Therapeutics Industry Trends
        2.3.2 Microbiome Therapeutics Market Drivers
        2.3.3 Microbiome Therapeutics Market Challenges
        2.3.4 Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Microbiome Therapeutics Players by Revenue
        3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue
    3.4 Global Microbiome Therapeutics Market Concentration Ratio
        3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2021
    3.5 Microbiome Therapeutics Key Players Head office and Area Served
    3.6 Key Players Microbiome Therapeutics Product Solution and Service
    3.7 Date of Enter into Microbiome Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapeutics Breakdown Data by Type
    4.1 Global Microbiome Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2023-2028)
5 Microbiome Therapeutics Breakdown Data by Application
    5.1 Global Microbiome Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Microbiome Therapeutics Market Size (2017-2028)
    6.2 North America Microbiome Therapeutics Market Size by Type
        6.2.1 North America Microbiome Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Microbiome Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Microbiome Therapeutics Market Share by Type (2017-2028)
    6.3 North America Microbiome Therapeutics Market Size by Application
        6.3.1 North America Microbiome Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Microbiome Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Microbiome Therapeutics Market Share by Application (2017-2028)
    6.4 North America Microbiome Therapeutics Market Size by Country
        6.4.1 North America Microbiome Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Microbiome Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Microbiome Therapeutics Market Size (2017-2028)
    7.2 Europe Microbiome Therapeutics Market Size by Type
        7.2.1 Europe Microbiome Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Microbiome Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Microbiome Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Microbiome Therapeutics Market Size by Application
        7.3.1 Europe Microbiome Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Microbiome Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Microbiome Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Microbiome Therapeutics Market Size by Country
        7.4.1 Europe Microbiome Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Microbiome Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Microbiome Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Microbiome Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Microbiome Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Microbiome Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Microbiome Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Microbiome Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Microbiome Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Microbiome Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Microbiome Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Microbiome Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Microbiome Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Microbiome Therapeutics Market Size (2017-2028)
    9.2 Latin America Microbiome Therapeutics Market Size by Type
        9.2.1 Latin America Microbiome Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Microbiome Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Microbiome Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Microbiome Therapeutics Market Size by Application
        9.3.1 Latin America Microbiome Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Microbiome Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Microbiome Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Microbiome Therapeutics Market Size by Country
        9.4.1 Latin America Microbiome Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Microbiome Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Microbiome Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Microbiome Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Microbiome Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Microbiome Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Microbiome Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Microbiome Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Microbiome Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Microbiome Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Microbiome Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Seres Therapeutics
        11.1.1 Seres Therapeutics Company Details
        11.1.2 Seres Therapeutics Business Overview
        11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction
        11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2017-2022)
        11.1.5 Seres Therapeutics Recent Developments
    11.2 Assembly Biosciences
        11.2.1 Assembly Biosciences Company Details
        11.2.2 Assembly Biosciences Business Overview
        11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction
        11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2017-2022)
        11.2.5 Assembly Biosciences Recent Developments
    11.3 Synthetic Biologics
        11.3.1 Synthetic Biologics Company Details
        11.3.2 Synthetic Biologics Business Overview
        11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction
        11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2017-2022)
        11.3.5 Synthetic Biologics Recent Developments
    11.4 Interxon
        11.4.1 Interxon Company Details
        11.4.2 Interxon Business Overview
        11.4.3 Interxon Microbiome Therapeutics Introduction
        11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2017-2022)
        11.4.5 Interxon Recent Developments
    11.5 PureTech
        11.5.1 PureTech Company Details
        11.5.2 PureTech Business Overview
        11.5.3 PureTech Microbiome Therapeutics Introduction
        11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2017-2022)
        11.5.5 PureTech Recent Developments
    11.6 Synlogic
        11.6.1 Synlogic Company Details
        11.6.2 Synlogic Business Overview
        11.6.3 Synlogic Microbiome Therapeutics Introduction
        11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2017-2022)
        11.6.5 Synlogic Recent Developments
    11.7 Enterome BioScience
        11.7.1 Enterome BioScience Company Details
        11.7.2 Enterome BioScience Business Overview
        11.7.3 Enterome BioScience Microbiome Therapeutics Introduction
        11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2017-2022)
        11.7.5 Enterome BioScience Recent Developments
    11.8 4D Pharma
        11.8.1 4D Pharma Company Details
        11.8.2 4D Pharma Business Overview
        11.8.3 4D Pharma Microbiome Therapeutics Introduction
        11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2017-2022)
        11.8.5 4D Pharma Recent Developments
    11.9 Second Genome
        11.9.1 Second Genome Company Details
        11.9.2 Second Genome Business Overview
        11.9.3 Second Genome Microbiome Therapeutics Introduction
        11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2017-2022)
        11.9.5 Second Genome Recent Developments
    11.10 AOBiome
        11.10.1 AOBiome Company Details
        11.10.2 AOBiome Business Overview
        11.10.3 AOBiome Microbiome Therapeutics Introduction
        11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2017-2022)
        11.10.5 AOBiome Recent Developments
    11.11 C3 Jian
        11.11.1 C3 Jian Company Details
        11.11.2 C3 Jian Business Overview
        11.11.3 C3 Jian Microbiome Therapeutics Introduction
        11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2017-2022)
        11.11.5 C3 Jian Recent Developments
    11.12 Rebiotix
        11.12.1 Rebiotix Company Details
        11.12.2 Rebiotix Business Overview
        11.12.3 Rebiotix Microbiome Therapeutics Introduction
        11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2017-2022)
        11.12.5 Rebiotix Recent Developments
    11.13 MicroBiome Therapeutics LLC
        11.13.1 MicroBiome Therapeutics LLC Company Details
        11.13.2 MicroBiome Therapeutics LLC Business Overview
        11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction
        11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2017-2022)
        11.13.5 MicroBiome Therapeutics LLC Recent Developments
    11.14 Metabiomics
        11.14.1 Metabiomics Company Details
        11.14.2 Metabiomics Business Overview
        11.14.3 Metabiomics Microbiome Therapeutics Introduction
        11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2017-2022)
        11.14.5 Metabiomics Recent Developments
    11.15 Ritter Pharmaceuticals
        11.15.1 Ritter Pharmaceuticals Company Details
        11.15.2 Ritter Pharmaceuticals Business Overview
        11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction
        11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2017-2022)
        11.15.5 Ritter Pharmaceuticals Recent Developments
    11.16 Symberix
        11.16.1 Symberix Company Details
        11.16.2 Symberix Business Overview
        11.16.3 Symberix Microbiome Therapeutics Introduction
        11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2017-2022)
        11.16.5 Symberix Recent Developments
    11.17 OpenBiome
        11.17.1 OpenBiome Company Details
        11.17.2 OpenBiome Business Overview
        11.17.3 OpenBiome Microbiome Therapeutics Introduction
        11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2017-2022)
        11.17.5 OpenBiome Recent Developments
    11.18 Azitra
        11.18.1 Azitra Company Details
        11.18.2 Azitra Business Overview
        11.18.3 Azitra Microbiome Therapeutics Introduction
        11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2017-2022)
        11.18.5 Azitra Recent Developments
    11.19 Symbiotix Biotherapies
        11.19.1 Symbiotix Biotherapies Company Details
        11.19.2 Symbiotix Biotherapies Business Overview
        11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction
        11.19.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2017-2022)
        11.19.5 Symbiotix Biotherapies Recent Developments
    11.20 Osel
        11.20.1 Osel Company Details
        11.20.2 Osel Business Overview
        11.20.3 Osel Microbiome Therapeutics Introduction
        11.20.4 Osel Revenue in Microbiome Therapeutics Business (2017-2022)
        11.20.5 Osel Recent Developments
    11.21 Metabogen
        11.21.1 Metabogen Company Details
        11.21.2 Metabogen Business Overview
        11.21.3 Metabogen Microbiome Therapeutics Introduction
        11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2017-2022)
        11.21.5 Metabogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Upper GIT
    Table 3. Key Players of Lower GIT
    Table 4. Global Microbiome Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Microbiome Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Microbiome Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Microbiome Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Microbiome Therapeutics Market Share by Region (2023-2028)
    Table 10. Microbiome Therapeutics Market Trends
    Table 11. Microbiome Therapeutics Market Drivers
    Table 12. Microbiome Therapeutics Market Challenges
    Table 13. Microbiome Therapeutics Market Restraints
    Table 14. Global Microbiome Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Microbiome Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Microbiome Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2021)
    Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Microbiome Therapeutics Product Solution and Service
    Table 21. Date of Enter into Microbiome Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Microbiome Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Microbiome Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Microbiome Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Microbiome Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Microbiome Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Seres Therapeutics Company Details
    Table 62. Seres Therapeutics Business Overview
    Table 63. Seres Therapeutics Microbiome Therapeutics Product
    Table 64. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Seres Therapeutics Recent Developments
    Table 66. Assembly Biosciences Company Details
    Table 67. Assembly Biosciences Business Overview
    Table 68. Assembly Biosciences Microbiome Therapeutics Product
    Table 69. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Assembly Biosciences Recent Developments
    Table 71. Synthetic Biologics Company Details
    Table 72. Synthetic Biologics Business Overview
    Table 73. Synthetic Biologics Microbiome Therapeutics Product
    Table 74. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Synthetic Biologics Recent Developments
    Table 76. Interxon Company Details
    Table 77. Interxon Business Overview
    Table 78. Interxon Microbiome Therapeutics Product
    Table 79. Interxon Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Interxon Recent Developments
    Table 81. PureTech Company Details
    Table 82. PureTech Business Overview
    Table 83. PureTech Microbiome Therapeutics Product
    Table 84. PureTech Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. PureTech Recent Developments
    Table 86. Synlogic Company Details
    Table 87. Synlogic Business Overview
    Table 88. Synlogic Microbiome Therapeutics Product
    Table 89. Synlogic Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Synlogic Recent Developments
    Table 91. Enterome BioScience Company Details
    Table 92. Enterome BioScience Business Overview
    Table 93. Enterome BioScience Microbiome Therapeutics Product
    Table 94. Enterome BioScience Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Enterome BioScience Recent Developments
    Table 96. 4D Pharma Company Details
    Table 97. 4D Pharma Business Overview
    Table 98. 4D Pharma Microbiome Therapeutics Product
    Table 99. 4D Pharma Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. 4D Pharma Recent Developments
    Table 101. Second Genome Company Details
    Table 102. Second Genome Business Overview
    Table 103. Second Genome Microbiome Therapeutics Product
    Table 104. Second Genome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Second Genome Recent Developments
    Table 106. AOBiome Company Details
    Table 107. AOBiome Business Overview
    Table 108. AOBiome Microbiome Therapeutics Product
    Table 109. AOBiome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. AOBiome Recent Developments
    Table 111. C3 Jian Company Details
    Table 112. C3 Jian Business Overview
    Table 113. C3 Jian Microbiome Therapeutics Product
    Table 114. C3 Jian Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. C3 Jian Recent Developments
    Table 116. Rebiotix Company Details
    Table 117. Rebiotix Business Overview
    Table 118. Rebiotix Microbiome Therapeutics Product
    Table 119. Rebiotix Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. Rebiotix Recent Developments
    Table 121. MicroBiome Therapeutics LLC Company Details
    Table 122. MicroBiome Therapeutics LLC Business Overview
    Table 123. MicroBiome Therapeutics LLC Microbiome Therapeutics Product
    Table 124. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 125. MicroBiome Therapeutics LLC Recent Developments
    Table 126. Metabiomics Company Details
    Table 127. Metabiomics Business Overview
    Table 128. Metabiomics Microbiome Therapeutics Product
    Table 129. Metabiomics Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 130. Metabiomics Recent Developments
    Table 131. Ritter Pharmaceuticals Company Details
    Table 132. Ritter Pharmaceuticals Business Overview
    Table 133. Ritter Pharmaceuticals Microbiome Therapeutics Product
    Table 134. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 135. Ritter Pharmaceuticals Recent Developments
    Table 136. Symberix Company Details
    Table 137. Symberix Business Overview
    Table 138. Symberix Microbiome Therapeutics Product
    Table 139. Symberix Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 140. Symberix Recent Developments
    Table 141. OpenBiome Company Details
    Table 142. OpenBiome Business Overview
    Table 143. OpenBiome Microbiome Therapeutics Product
    Table 144. OpenBiome Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 145. OpenBiome Recent Developments
    Table 146. Azitra Company Details
    Table 147. Azitra Business Overview
    Table 148. Azitra Microbiome Therapeutics Product
    Table 149. Azitra Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 150. Azitra Recent Developments
    Table 151. Symbiotix Biotherapies Company Details
    Table 152. Symbiotix Biotherapies Business Overview
    Table 153. Symbiotix Biotherapies Microbiome Therapeutics Product
    Table 154. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 155. Symbiotix Biotherapies Recent Developments
    Table 156. Osel Company Details
    Table 157. Osel Business Overview
    Table 158. Osel Microbiome Therapeutics Product
    Table 159. Osel Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 160. Osel Recent Developments
    Table 161. Metabogen Company Details
    Table 162. Metabogen Business Overview
    Table 163. Metabogen Microbiome Therapeutics Product
    Table 164. Metabogen Revenue in Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 165. Metabogen Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Microbiome Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Upper GIT Features
    Figure 3. Lower GIT Features
    Figure 4. Global Microbiome Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. C. difficile Infection (CDI) Case Studies
    Figure 6. Inflammatory Bowel Disease (IBD) Case Studies
    Figure 7. Orphan Drug Case Studies
    Figure 8. Immuno-oncology Case Studies
    Figure 9. Others Case Studies
    Figure 10. Microbiome Therapeutics Report Years Considered
    Figure 11. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Microbiome Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Microbiome Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Microbiome Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2021
    Figure 17. North America Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Microbiome Therapeutics Market Size Share by Country (2017-2028)
    Figure 21. United States Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Microbiome Therapeutics Market Size Share by Country (2017-2028)
    Figure 27. Germany Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Microbiome Therapeutics Market Size Share by Region (2017-2028)
    Figure 37. China Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Microbiome Therapeutics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Microbiome Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Microbiome Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Microbiome Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Microbiome Therapeutics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 57. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 58. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 59. Interxon Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 60. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 61. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 62. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 63. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 64. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 65. AOBiome Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 66. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 67. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 68. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 69. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 70. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 71. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 72. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 73. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 74. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 75. Osel Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 76. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed